(Q41731235)

8 October 2017

1 reference

title

Acute treatment of atrial fibrillation: why and when to maintain sinus rhythm (English)

1 reference

8 October 2017

1 reference

2

A J Camm

1 reference

8 October 2017

J E Waktare

1

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Cardiology

8 October 2017

published in

1 reference

8 October 2017

volume

81

1 reference

8 October 2017

issue

5A

1 reference

8 October 2017

page(s)

3C-15C

1 reference

ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Classification of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Transcranial Doppler evaluation of cerebral blood flow in patients with paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The effect of cardioversion on exercise capacity in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Functional capacity before and after cardioversion of atrial fibrillation: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Improved ventilatory response to exercise after cardioversion of chronic atrial fibrillation to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Metabolic and hemodynamic responses to exercise during atrial fibrillation and sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Alterations in Cardiac Function Immediately Following Electrical Conversion of Atrial Fibrillation to Normal Sinus Rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The Hemodynamic Importance of Atrial Systole: A Function of the Kinetic Energy of Blood Flow?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Anticoagulants: when and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Electrical reversion of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Silent cerebral infarction in chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Atrial fibrillation and atrial enlargement in patients with mitral stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Relation between left atrial dimension and duration of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Atrial function after cardioversion for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Reversion of tachycardiomyopathy after beta-blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

A randomized comparison of external and internal cardioversion of chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The optimal technique for electrical cardioversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Optimal Parameters of Electrical Impulses for Defibrillation by Condenser Discharges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

THE TECHNIQUE OF CARDIOVERSION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Appraisal of electroconversion in treatment of cardiac dysrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Elective Cardioversion: Influence of Paddle-Electrode Location and Size on Success Rates and Energy Requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effects of flecainide on the atrial defibrillation threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

The use of quinidine in cardioversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Amiodarone in the management of refractory atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Low-energy internal cardioversion for atrial fibrillation resistant to external cardioversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Restoration and maintenance of sinus rhythm after mitral valve surgery for mitral stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Amiodarone for refractory atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Antithrombotic therapy in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effects of diltiazem, propranolol, and their combination in the control of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Diltiazem and exercise performance in patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900181-7

10.1016/S0002-9149(98)00181-7

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference